PodParley PodParley

Seizures (15 May 2023)

In this episode, Dr Marilena Giannoudi discusses …

An episode of the Clinical Conversations podcast, hosted by Royal College of Physicians of Edinburgh, titled "Seizures (15 May 2023)" was published on May 15, 2023 and runs 29 minutes.

May 15, 2023 ·29m · Clinical Conversations

0:00 / 0:00

In this episode, Dr Marilena Giannoudi discusses the role of the 'first fit' clinic and seizure diagnosis and management with Dr Richard Davenport. Dr Richard Davenport has been a Consultant Neurologist since 1999. While very much a general neurologist, he undertakes NHS first seizure, movement disorder and MND clinics, and has particular interests in education and training. Dr Davenport became President of the Association of British Neurologists (ABN) in May 2023. Outside of neurology, Dr Davenport enjoys cycling. Dr Marilena Giannoudi is the T&MC Podcast Lead and Vice-Chair for Careers and Communications. -- Link -- https://www.gov.uk/epilepsy-and-driving Recording date: 24 January 2023 -- Follow us -- https://www.instagram.com/rcpedintrainees https://twitter.com/RCPEdinTrainees -- Upcoming RCPE Events -- https://events.rcpe.ac.uk/ Feedback: [email protected]

In this episode, Dr Marilena Giannoudi discusses the role of the 'first fit' clinic and seizure diagnosis and management with Dr Richard Davenport. Dr Richard Davenport has been a Consultant Neurologist since 1999. While very much a general neurologist, he undertakes NHS first seizure, movement disorder and MND clinics, and has particular interests in education and training. Dr Davenport became President of the Association of British Neurologists (ABN) in May 2023. Outside of neurology, Dr Davenport enjoys cycling. Dr Marilena Giannoudi is the T&MC Podcast Lead and Vice-Chair for Careers and Communications. -- Link -- https://www.gov.uk/epilepsy-and-driving Recording date: 24 January 2023 -- Follow us -- https://www.instagram.com/rcpedintrainees https://twitter.com/RCPEdinTrainees -- Upcoming RCPE Events -- https://events.rcpe.ac.uk/ Feedback: [email protected]
Clinical Trial Podcast | Conversations with Clinical Research Experts Kunal Sampat | Educator Clinical research and clinical trial management form the backbone of drug and device approvals worldwide. Learn from the leading industry experts to build and advance your clinical research career.You'll hear from sponsors, clinical research organizations, and clinical trial sites around the globe. This show is for all current and aspiring clinical research professionals including clinical research associates (CRA), clinical operations managers, study managers, biostatisticians, medical doctors, safety monitors, clinical scientists and other healthcare professionals. To learn more, visit https://clinicaltrialpodcast.com/ Primary Care Today ReachMD Primary Care Today features conversations with clinical experts representing a wide range of medical specialties to highlight the latest trends in primary care practice, from clinical pearls to updated guidelines, health informatics, and practice management. This series is hosted by Dr. Brian McDonough, a nationally recognized clinical expert, teacher, and public speaker in primary care. Few & Far Between: How Biotech Gets Built Chris O'Brien Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders. Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere Julio G. Martinez-Clark Hosted by bioaccess® CEO, Julio G. Martinez-Clark, the Global Trial Accelerators™ podcast delivers actionable insights for Medtech, Biopharma, and Radiopharma innovators battling lengthy timelines and costly delays. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and startup founders who’ve slashed 6–12 months off approvals by leveraging emerging regions like Latin America, Eastern Europe, and Australia.What You’ll Learn:Speed Secrets: How to secure ethics approval in 4–6 weeks (vs. 6+ months in US/EU) using harmonized pathways like MINSA (Panama), ALIMS (Serbia), and Australia’s CTN.Cost-to-Speed Hacks: Operational strategies to reduce trial budgets by 30% while maintaining FDA/EMA compliance.Global Patient Access: Leverage treatment-naive populations in cardiology, rare diseases, and advanced therapies across 50+ pre-vetted sites.Why Listen?<ul
URL copied to clipboard!